(Q36260616)
Statements
CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations (English)
Anchit Khanna
Jayant K Rane
Kati K Kivinummi
Merja A Helenius
Teemu T Tolonen
Visa Manni
John E Pimanda
Norman J Maitland
Jukka Westermarck